financetom
Business
financetom
/
Business
/
JPMorgan Chase & Insider Sold Shares Worth $1,536,931, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
JPMorgan Chase & Insider Sold Shares Worth $1,536,931, According to a Recent SEC Filing
May 26, 2025 2:30 AM

03:32 AM EDT, 05/07/2025 (MT Newswires) -- Jennifer Piepszak, Chief Operating Officer, on May 06, 2025, sold 6,129 shares in JPMorgan Chase ( JPM ) & (JPM) for $1,536,931. Following the Form 4 filing with the SEC, Piepszak has control over a total of 68,583 common shares of the company, with 68,583 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/19617/000122520825004803/xslF345X05/doc4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Matthews International Fiscal Q4 Adjusted Earnings, Revenue Fall
Matthews International Fiscal Q4 Adjusted Earnings, Revenue Fall
Nov 20, 2025
04:27 PM EST, 11/20/2025 (MT Newswires) -- Matthews International ( MATW ) reported fiscal Q4 adjusted earnings late Thursday of $0.50 per share, down from $0.55 a year earlier. Two analysts polled by FactSet expected $0.20. Revenue for the three months ended Sept. 30 was $318.8 million, down from $446.7 million a year earlier. Two analysts surveyed by FactSet expected...
Revolution Medicines Insider Sold Shares Worth $939,008, According to a Recent SEC Filing
Revolution Medicines Insider Sold Shares Worth $939,008, According to a Recent SEC Filing
Nov 20, 2025
04:29 PM EST, 11/20/2025 (MT Newswires) -- Jeff Cislini, General Counsel, on November 18, 2025, sold 13,388 shares in Revolution Medicines ( RVMD ) for $939,008. Following the Form 4 filing with the SEC, Cislini has control over a total of 50,425 common shares of the company, with 50,425 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1628171/000161071725000383/xslF345X05/form4.xml ...
Revolution Medicines Insider Sold Shares Worth $1,407,586, According to a Recent SEC Filing
Revolution Medicines Insider Sold Shares Worth $1,407,586, According to a Recent SEC Filing
Nov 20, 2025
04:29 PM EST, 11/20/2025 (MT Newswires) -- Mark A Goldsmith, Director, President and Chief Executive Officer, on November 18, 2025, sold 20,000 shares in Revolution Medicines ( RVMD ) for $1,407,586. Following the Form 4 filing with the SEC, Goldsmith has control over a total of 958,761 common shares of the company, with 247,863 shares held directly and 710,898 controlled...
Atlassian Insider Sold Shares Worth $444,896, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $444,896, According to a Recent SEC Filing
Nov 20, 2025
04:30 PM EST, 11/20/2025 (MT Newswires) -- Rajeev Bashyam Rajan, Chief Technology Officer, on November 19, 2025, sold 3,017 shares in Atlassian ( TEAM ) for $444,896. Following the Form 4 filing with the SEC, Rajan has control over a total of 219,997 Class A common shares of the company, with 219,997 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000194361425000004/xslF345X05/primarydocument.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved